Clinical trial
Intravenous Magnesium Sulfate in Aneurysmal Subarachnoid Haemorrhage (IMASH)
NCT00124150 · Chinese University of Hong Kong, Other · Completed
Key facts
| NCT number | NCT00124150 |
|---|---|
| Title | Intravenous Magnesium Sulfate in Aneurysmal Subarachnoid Haemorrhage (IMASH) |
| Official title | Phase 3 Study (Multi-center, Randomized Controlled Clinical Trial) of Intravenous Magnesium Sulfate to Improve Outcome After Aneurysmal Subarachnoid Haemorrhage |
| Lead sponsor | Chinese University of Hong Kong, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Subarachnoid Hemorrhage |
| Intervention type | Drug |
| Interventions | Intravenous magnesium sulfate infusion |
| Enrollment | 327 |
| Start date | Jun 1, 2002 |
| Primary completion | Dec 1, 2008 |
| Completion | Jun 1, 2009 |
| First posted | Jul 27, 2005 |
| Last update posted | Dec 23, 2009 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: